×
Dr Dodds Replies PDF
$ 40.00
Dr Dodds Replies PDF quantity
$ 40.00
×
Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients PDF
$ 40.00
Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients PDF quantity
$ 40.00
×
Psychological Impact of the COVID-19 Pandemic and Associated Lockdown on Outpatients With Psychiatric Illness: A Cross-Sectional Study PDF
$ 40.00
Psychological Impact of the COVID-19 Pandemic and Associated Lockdown on Outpatients With Psychiatric Illness: A Cross-Sectional Study PDF quantity
$ 40.00
×
A Breathing-Based Meditation Intervention for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study PDF
$ 40.00
A Breathing-Based Meditation Intervention for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study PDF quantity
$ 40.00
×
Association of Internet Addiction and Mental Disorders in Medical Students: A Systematic Review PDF
$ 40.00
Association of Internet Addiction and Mental Disorders in Medical Students: A Systematic Review PDF quantity
$ 40.00
×
Toxoplasma gondii Immunoglobulin G Antibodies and Nonfatal Suicidal Self-Directed Violence PDF
$ 40.00
Toxoplasma gondii Immunoglobulin G Antibodies and Nonfatal Suicidal Self-Directed Violence PDF quantity
$ 40.00
×
Doxepin in the Treatment of Primary Insomnia: A Placebo-Controlled, Double-Blind, Polysomnographic Study PDF
$ 40.00
Doxepin in the Treatment of Primary Insomnia: A Placebo-Controlled, Double-Blind, Polysomnographic Study PDF quantity
$ 40.00
×
A Double-Blind, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness in Patients With Treated Obstructive Sleep Apnea and Comorbid Depression PDF
$ 40.00
A Double-Blind, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness in Patients With Treated Obstructive Sleep Apnea and Comorbid Depression PDF quantity
$ 40.00
×
Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart